167 related articles for article (PubMed ID: 11451447)
1. A constitutively active pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor shows enhanced photoaffinity labeling of its highly glycosylated form.
Cao Y; Gimpl G
Biochim Biophys Acta; 2001 Jul; 1548(1):139-51. PubMed ID: 11451447
[TBL] [Abstract][Full Text] [Related]
2. Photoaffinity labeling analysis of the interaction of pituitary adenylate-cyclase-activating polypeptide (PACAP) with the PACAP type I receptor.
Cao YJ; Kojro E; Gimpl G; Jasionowski M; Kasprzykowski F; Lankiewicz L; Fahrenholz F
Eur J Biochem; 1997 Mar; 244(2):400-6. PubMed ID: 9119005
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation.
Cao YJ; Gimpl G; Fahrenholz F
FEBS Lett; 2000 Mar; 469(2-3):142-6. PubMed ID: 10713259
[TBL] [Abstract][Full Text] [Related]
4. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
[TBL] [Abstract][Full Text] [Related]
5. Identification of binding domains of pituitary adenylate cyclase activating polypeptide (PACAP) for its type 1 receptor by photoaffinity labeling.
Cao YJ; Kojro E; Jasionowski M; Lankiewicz L; Grzonka Z; Fahrenholz F
Ann N Y Acad Sci; 1998 Dec; 865():82-91. PubMed ID: 9928000
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
8. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B
J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876
[TBL] [Abstract][Full Text] [Related]
9. Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain.
Hu Z; Lelievre V; Chao A; Zhou X; Waschek JA
Endocrinology; 2000 Feb; 141(2):657-65. PubMed ID: 10650947
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
11. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
[TBL] [Abstract][Full Text] [Related]
12. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
13. [Pituitary adenylate cyclase-activating polypeptide].
Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
[TBL] [Abstract][Full Text] [Related]
14. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury.
Jaworski DM
Cell Tissue Res; 2000 May; 300(2):219-30. PubMed ID: 10867818
[TBL] [Abstract][Full Text] [Related]
15. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
16. The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain.
Cao YJ; Gimpl G; Fahrenholz F
Biochem Biophys Res Commun; 1995 Jul; 212(2):673-80. PubMed ID: 7626082
[TBL] [Abstract][Full Text] [Related]
17. Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons.
Miampamba M; Germano PM; Arli S; Wong HH; Scott D; Taché Y; Pisegna JR
Regul Pept; 2002 May; 105(3):145-54. PubMed ID: 11959368
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
Hashimoto H; Ogawa N; Hagihara N; Yamamoto K; Imanishi K; Nogi H; Nishino A; Fujita T; Matsuda T; Nagata S; Baba A
Mol Pharmacol; 1997 Jul; 52(1):128-35. PubMed ID: 9224822
[TBL] [Abstract][Full Text] [Related]
19. Molecular structure analysis of the pituitary adenylate cyclase activating polypeptide type I receptor from pig brain.
Cao YJ; Gimpl G; Fahrenholz F
Biochim Biophys Acta; 1994 Jul; 1222(3):432-40. PubMed ID: 8038212
[TBL] [Abstract][Full Text] [Related]
20. Mice with markedly reduced PACAP (PAC(1)) receptor expression by targeted deletion of the signal peptide.
Hashimoto H; Shintani N; Nishino A; Okabe M; Ikawa M; Matsuyama S; Itoh K; Yamamoto K; Tomimoto S; Fujita T; Hagihara N; Mori W; Koyama Y; Matsuda T; Nagata S; Baba A
J Neurochem; 2000 Nov; 75(5):1810-7. PubMed ID: 11032869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
